Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
At its Baltimore, MD location, Sinai Hospital provides extensive outpatient services designed for adults and young adults struggling with substance use. This center is particularly adept at addressing dual diagnoses, where substance use disorders are present with significant mental health conditions or emotional challenges. Employing scientifically validated methods including anger management, cognitive behavioral therapy, and motivational reinforcement, Sinai Hospital crafts individualized recovery paths. They offer distinct programs catering to adult men, adult women, and individuals managing both mental health and substance use issues concurrently. Committed to delivering high-standard, individualized care, Sinai Hospital actively assists individuals in achieving lasting recovery.
Sioux Falls VAHCS, located in Sioux Falls, SD, delivers extensive addiction recovery programs for adults and adolescents. Their offerings include robust outpatient care, including detoxification and specialized services for those with co-occurring mental health and substance use conditions. Emphasizing strategies like 12-step facilitation, anger management techniques, and brief intervention methods, this center supports individuals who have faced intimate partner violence, trauma, or domestic abuse. Sioux Falls VAHCS welcomes both men and women, dedicated to providing excellent support for each person's path to healing.
Located in Sioux Falls, SD, Sioux Falls Treatment Center LLC specializes in outpatient detox services and treatment for substance use disorders, offering methadone, buprenorphine, and naltrexone options for both adults and young adults. The center employs evidence-based techniques, including brief interventions, cognitive-behavioral therapy, and motivational incentives, making it distinct for its tailored treatment plans. Their commitment to quality care ensures a nurturing atmosphere for clients of all genders who are in search of effective, personalized support in overcoming addiction.
Sinnissippi Centers Inc., located in Rochelle, IL, delivers thorough support for substance use disorders, including dedicated services for those facing concurrent serious mental health conditions or emotional challenges. Their offerings encompass intensive outpatient, outpatient, and medication-assisted treatment options (methadone/buprenorphine or naltrexone), all grounded in proven methods such as 12-step facilitation, anger management, and brief intervention. The center features distinct programs designed for adolescents, adult men, and adult women, and welcomes adults and seniors of any gender. Prioritizing high-quality, personalized care, Sinnissippi Centers Inc. is committed to guiding individuals through their recovery process.
Hospital inpatient and residential detoxification, plus short and long-term residential care, are provided at Simonds Detox in Granada Hills, California for adults and seniors. Buprenorphine and naltrexone are used in treatment. TRICARE, private insurance, and self-pay are accepted, with a sliding fee scale based on income.
Located in Burley, Idaho, this outpatient program treats substance use and co-occurring serious mental illness in adults and serious emotional disturbance in children, with naltrexone used in treatment. Adolescents through seniors are served, including veterans and military families. No payment is accepted for services, and Spanish and sign language services are offered.
Sinai Addiction Recovery provides outpatient detoxification and medication treatment in Baltimore, Maryland, using buprenorphine and naltrexone. Programs serve adult women and men, including clients with co-occurring mental and substance use disorders. Medicare, Medicaid, private insurance, and self-payment are accepted.
Sinnissippi Centers Inc, located in Dixon, IL, provides targeted treatment for adults dealing with substance use issues and serious co-occurring mental health disorders, as well as for children facing emotional challenges. The center offers both intensive outpatient and standard outpatient services, including methadone and buprenorphine options. By implementing 12-step strategies, anger management techniques, and brief therapy sessions, the facility supports a diverse clientele, including adult men and women, adolescents, and seniors, with dedicated programs tailored for each gender. Emphasizing personalized care and evidence-driven methods, the center aims to deliver effective treatment to those in pursuit of recovery from addiction and mental health difficulties.
Sinnissippi Centers Inc, situated in Sterling, IL, delivers comprehensive rehabilitation programs. The facility excels in addressing addiction, supporting adults with co-occurring mental health conditions and children facing significant emotional challenges. Services are available in intensive outpatient and standard outpatient formats, with medication-assisted treatment options including methadone, buprenorphine, or naltrexone. Program methodologies encompass 12-step facilitation, anger management techniques, and brief intervention strategies. Sinnissippi Centers Inc features tailored programs for active military members, teenagers, and adult men. Catering to individuals of all ages, including seniors, and both genders, the center is dedicated to providing personalized care and encouragement for individuals on their recovery journey.
Sinnissippi Centers Inc in Oregon, IL, delivers extensive outpatient care for substance use disorders in both adults and youth facing concurrent severe mental health conditions. Their specialized offerings include medication-assisted treatment with methadone, buprenorphine, or naltrexone, alongside 12-step program support, anger management techniques, and brief intervention strategies. The center features customized treatment plans for military personnel, teenagers, and adult men, addressing the needs of various groups. Catering to individuals of all ages and genders, Sinnissippi Centers Inc is committed to delivering high-quality, evidence-informed services to aid in the recovery journey.
Sinnissippi Centers Inc, situated in Dixon, IL, delivers thorough recovery programs for adult men addressing addiction and co-occurring mental health challenges. They offer intensive outpatient and standard outpatient care, incorporating methadone/buprenorphine treatment. Sinnissippi Centers Inc also has dedicated programs for active military members and survivors of domestic abuse, customizing their strategies for each individual's specific circumstances. Employing proven techniques such as 12-step facilitation and anger management, this establishment provides excellent care for adults and older adults pursuing sobriety within a supportive, male-oriented setting.
Sisters Health Center Amherst offers outpatient substance use treatment in Buffalo, New York, through its STAR Program, using buprenorphine and naltrexone. Adult women and men from young adulthood through senior years are served. Medicare, Medicaid, TRICARE, private insurance, and state-financed health plans are accepted.
Methadone treatment for opioid use disorder is provided on an outpatient basis at the Pathways program of Sisters Health Center Amherst in Buffalo, New York. Adult women and men are served across young adult, adult, and senior age groups. Medicare, Medicaid, TRICARE, private insurance, and state-financed health plans are accepted.
Methadone maintenance is provided on an outpatient basis at this Rochester, New York program operated by Sisters of Charity Hospital. Adult women and men from young adulthood through senior years are served. Medicare, Medicaid, TRICARE, private insurance, and state-financed health plans are accepted.
Sisters of Charity Hospital's STAR Saint Vincent program in Buffalo, New York provides outpatient substance use treatment for young adults, adults, and seniors, including buprenorphine for opioid use disorder. Payment options include Medicare, Medicaid, TRICARE, private insurance, and state-financed health plans.
Pathways Buffalo, a Sisters of Charity Hospital program in Buffalo, New York, offers outpatient methadone treatment for opioid use disorder alongside regular outpatient care for adult women and men. Young adults and seniors are also served. Medicare, Medicaid, TRICARE, private insurance, and self-payment are accepted.
Hospital inpatient substance use treatment in Buffalo, New York, serving adult women and men, including clients with co-occurring mental and substance use disorders. Buprenorphine and naltrexone are used in treatment. Medicare, Medicaid, TRICARE, tribal funds, private insurance, and self-payment are accepted. Young adults, adults, and seniors are served.
Sinnissippi Centers Inc, located in Freeport, IL, provides a wide range of services for people dealing with substance use disorders, along with specialized support for those facing both substance use and significant mental health challenges. The center features multiple treatment options, including intensive outpatient initiatives and outpatient services utilizing methadone, buprenorphine, or naltrexone. By emphasizing 12-step programs, anger management, and short intervention strategies, it serves active military members, teenagers, and adult males. Sinnissippi Centers Inc is committed to offering top-notch, gender-sensitive care that addresses the specific requirements of each person, including adults and seniors of any gender.
Sinnissippi Centers Inc, located in Mount Carroll, Illinois, delivers a wide range of services for individuals struggling with substance use issues and co-occurring mental health disorders. The facility specializes in intensive outpatient programs, outpatient care, and medication-assisted treatments involving methadone, buprenorphine, or naltrexone. It emphasizes 12-step support, anger management techniques, and brief intervention strategies. Catering to diverse populations, including adults, seniors, active-duty military personnel, adolescents, and adult males, the center provides customized treatment plans for both genders. With a strong dedication to high-quality, evidence-informed care, Sinnissippi Centers Inc is recognized as an excellent option for those in need of effective rehabilitation solutions.
Sinnissippi Centers Inc. in Amboy, Illinois, delivers extensive substance abuse recovery programs specifically designed for adult women facing addiction and concurrent mental health conditions. The center has developed unique support systems for those who have endured intimate partner abuse, domestic violence, or sexual assault. Their therapeutic approach emphasizes 12-step integration, strategies for managing anger, and rapid intervention techniques, offering both intensive outpatient and standard outpatient care. Sinnissippi Centers Inc. serves adult women across various age groups, including seniors and young adults, providing personalized assistance to clients striving for recovery from addiction and mental health issues in a nurturing setting.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.